Form 4: Bayview Legacy Sells Arteris Shares Under 10b5-1 Plan

Bayview Legacy, a 10% owner of Arteris Inc., reported sales of 130,000 common shares totaling approximately $2.29 million under a pre-arranged 10b5-1 trading plan.

Summary

• Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), reported the sale of 130,000 shares of common stock.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Bayview Legacy, LLC on March 5, 2025.
• On December 5, 2025, 60,000 shares were sold at a weighted average price of $17.0779 per share, with prices ranging from $16.75 to $17.36.
• On December 8, 2025, an additional 70,000 shares were sold at a weighted average price of $17.7138 per share, with prices ranging from $17.39 to $18.185.
• Following these transactions, Bayview Legacy, LLC beneficially owns 9,469,071 shares of Arteris, Inc. common stock.
• K. Charles Janac, as the manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over these shares and has filed a separate Form 4 for the same transactions.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider selling, although mitigated by the fact that the transactions were pre-planned under a Rule 10b5-1 plan, suggesting a scheduled divestment rather than a reaction to adverse news.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted on March 5, 2025, indicating a scheduled divestment rather than a reaction to recent company-specific news.

Negatives

• A significant insider sale of 130,000 shares by a 10% owner, even if pre-planned, reduces insider ownership and could be perceived by the market as a lack of confidence.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity and does not provide information directly related to broader industry trends or competitive landscape.

Related Party Transactions

• The sales of common stock by Bayview Legacy, LLC, a 10% owner and an entity controlled by K. Charles Janac (who is associated with Arteris), constitute related party transactions.

Stakeholder Impact

• Shareholders may interpret the insider selling as a signal, potentially influencing investor confidence, despite the pre-planned nature of the transactions.

Key Dates

Recommendation

While insider selling can be a negative signal, the transactions were executed under a pre-arranged 10b5-1 plan, which often indicates personal financial planning rather than a lack of confidence in the company's future. Without additional information on the company's fundamentals or other market factors, a 'hold' recommendation is appropriate, advising investors to monitor future developments and broader market trends for Arteris.

Keywords

Arteris, AIP, insider trading, Form 4, stock sale, 10b5-1 plan, Bayview Legacy, K. Charles Janac, beneficial ownership